Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
21
HRTX Quote, Financials, Valuation and Earnings
Last price:
$2.01
Seasonality move
:
-11.19%
Day range:
$2.00 - $2.05
52-week range:
$1.04 - $3.53
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.06x
P/B ratio:
--
Volume:
861.3K
Avg. volume:
1.4M
1-year change:
-42.86%
Market cap:
$305.1M
Revenue:
$144.3M
EPS (TTM):
-$0.05
Earnings Data
Next earnings date for HRTX
Aug 06
2025
Most recent earnings per share
$0.02
Beat by $0.03
(May 6/2025)
Consensus Estimate
-$0.01
(May 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
HRTX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $39.5M | -- | -- | -$0.00 | -- |
| 08/06/2025 | Q2 | $38.1M | -- | -- | -$0.01 | -- |
| 05/06/2025 | Q1 | $37.4M | $38.9M | $0.02 | -$0.01 | $0.03 |
| 02/27/2025 | Q4 | $37.4M | $40.8M | $0.02 | -$0.03 | $0.05 |
| 11/12/2024 | Q3 | $36.9M | $32.8M | -$0.03 | -$0.04 | $0.01 |
| 08/06/2024 | Q2 | $35.9M | $36M | -$0.06 | -$0.05 | -$0.01 |
| 05/07/2024 | Q1 | $33M | $34.7M | -$0.02 | -$0.09 | $0.07 |
| 03/12/2024 | Q4 | $31.2M | $34.2M | -$0.05 | -$0.15 | $0.10 |
| 11/14/2023 | Q3 | -- | -- | -$0.17 | -$0.31 | $0.14 |
| 08/14/2023 | Q2 | -- | -- | -$0.35 | -$0.23 | -$0.12 |
| 05/11/2023 | Q1 | -- | -- | -$0.27 | -$0.20 | -$0.07 |
| 03/23/2023 | Q4 | -- | -- | -$0.17 | -$0.37 | $0.20 |
| 11/08/2022 | Q3 | -- | -- | -$0.38 | -$0.39 | $0.01 |
| 08/09/2022 | Q2 | -- | -- | -$0.55 | -$0.54 | -$0.01 |
| 05/09/2022 | Q1 | -- | -- | -$0.63 | -$0.52 | -$0.11 |
| 02/28/2022 | Q4 | -- | -- | -$0.54 | -$0.57 | $0.02 |
| 11/03/2021 | Q3 | -- | -- | -$0.51 | -$0.60 | $0.09 |
| 08/09/2021 | Q2 | -- | -- | -$0.62 | -$0.57 | -$0.05 |
| 05/10/2021 | Q1 | -- | -- | -$0.58 | -$0.53 | -$0.05 |
| 02/24/2021 | Q4 | -- | -- | -$0.68 | -$0.63 | -$0.05 |
| 11/05/2020 | Q3 | -- | -- | -$0.64 | -$0.62 | -$0.02 |
| 08/05/2020 | Q2 | -- | -- | -$0.61 | -$0.60 | -$0.01 |
| 05/06/2020 | Q1 | -- | -- | -$0.57 | -$0.67 | $0.10 |
| 03/02/2020 | Q4 | -- | -- | -$0.65 | -$0.56 | -$0.09 |
| 11/12/2019 | Q3 | -- | -- | -$0.42 | -$0.58 | $0.16 |
| 08/05/2019 | Q2 | -- | -- | -$0.63 | -$0.62 | -$0.01 |
| 05/09/2019 | Q1 | -- | -- | -$0.80 | -$0.50 | -$0.30 |
| 02/22/2019 | Q4 | -- | -- | -$0.63 | -$0.47 | -$0.16 |
| 11/07/2018 | Q3 | -- | -- | -$0.49 | -$0.44 | -$0.05 |
| 08/08/2018 | Q2 | -- | -- | -$0.54 | -$0.68 | $0.14 |
| 05/10/2018 | Q1 | -- | -- | -$0.81 | -$0.88 | $0.07 |
| 02/27/2018 | Q4 | -- | -- | -$1.09 | -$0.79 | -$0.30 |
| 11/06/2017 | Q3 | -- | -- | -$0.77 | -$0.86 | $0.09 |
| 08/09/2017 | Q2 | -- | -- | -$0.80 | -$0.91 | $0.11 |
| 05/10/2017 | Q1 | -- | -- | -$1.00 | -$0.95 | -$0.05 |
| 02/23/2017 | Q4 | -- | -- | -$1.22 | -$1.23 | $0.01 |
| 11/08/2016 | Q3 | -- | -- | -- | -- | -- |
| 08/08/2016 | Q2 | -- | -- | -- | -- | -- |
| 05/05/2016 | Q1 | -- | -- | -- | -- | -- |
| 02/19/2016 | Q4 | -- | -- | -- | -- | -- |
| 11/06/2015 | Q3 | -- | -- | -- | -- | -- |
Heron Therapeutics Earnings Questions
-
How Much did Heron Therapeutics Generate in Revenue Last Quarter?
Heron Therapeutics reported $38.9M worth of top line sales in its most recent quarter.
-
Did Heron Therapeutics Beat Earnings Last Quarter?
Heron Therapeutics announced earnings per share of $0.02 which represents a beat of analyst forecast a -$0.01 per share.
-
Is Heron Therapeutics Profitable?
Heron Therapeutics reported $30.4M that represents $0.20 per share over the last quarter.
-
What is the Analyst Consensus for Heron Therapeutics EPS Next Year?
Heron Therapeutics's earnings are forecast to decrease from -$0.09 per share to -$0.12 per share next year representing a decrease of -96.3%.
-
When is Heron Therapeutics's Earnings Date?
Heron Therapeutics's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 0.83% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 13.12% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 5.29% over the past day.
